glp-1 drugs pharmaceutical companies news 2025 Receptor Agonist Market Valued at USD 62.86 Billion in 2025, Set to Grow at 17.5% CAGR Through 2034 GLP-1 Drugs: 2025 Pulse Survey

Mitchell AP, Magasanik B

SGLT2 inhibitors cause your kidneys to release more glucose into your urine and remove it from your body, which can lead to calorie loss

Dehydration represents a third major concern

However, medical articles report that some of us can have less naturally occurring glutathione in our body than others

I think AI is going to lead to a rise in people wanting more control and autonomy over their bodies, because there is a rising dissatisfaction or dissonance with medical science after Covid-19

The American Autoimmune Related Diseases Association (AARDA) estimates that about 20 million Americans have one or more forms of peripheral neuropathy